Literature DB >> 26910176

Why is nitric oxide important for our brain?

Eleonora Džoljić, Ivan Grbatinić, Vladimir Kostić.   

Abstract

The freely diffusible gaseous compound nitric oxide (NO) has been shown to be an important messenger in many organ systems throughout the body, and particularly in the central nervous system (CNS). The importance of NO as an intermediary in cell communication in the brain is highlighted by the fact that the excitatory amino acid glutamate, the most abundant CNS neurotransmitter, is an initiator of the reaction that forms NO. Because of its numerous physiological and pathophysiological roles, the impact of NO on clinical medicine is developing. NO can act as a "double-edged sword" and it has been demonstrated that clarification of the dual effect of NO might have implications for clinical medicine, and could lead to the emergence of therapeutic opportunities. Accordingly, NO was proclaimed "Mole cule of the Year" in 1992 by the journal Science, while discovery of the pathways and roles of NO was acknowledged with the Nobel Prize in 1998. Additionally, the ubiquity of NO in the CNS implies that drugs designed to modify the biological activity of NO may have distinct effects. Thus, further clinical applications of NO, of its analogs or of newly developed NOS inhibitors are forthcoming. The therapeutic challenge would be to succeed in manipulating the NO pathways selectively.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26910176      PMCID: PMC4610750          DOI: 10.11138/fneur/2015.30.3.159

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  47 in total

Review 1.  Nitric oxide neurotoxicity in neurodegenerative diseases.

Authors:  Kathleen M K Boje
Journal:  Front Biosci       Date:  2004-01-01

Review 2.  Nitric oxide and neurological disorders.

Authors:  Andrew J Duncan; Simon J R Heales
Journal:  Mol Aspects Med       Date:  2005-01-24

Review 3.  [Nitric oxide, neurodegeneration, and Parkinson's disease].

Authors:  Eleonora Dzoljić; Zorica Nesić; Radan Stojanović; Nevena Divac; Zoran Todorović; Sonja Vucković; Vladimir Kostić; Milica Prostran
Journal:  Vojnosanit Pregl       Date:  2005-10       Impact factor: 0.168

4.  Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease.

Authors:  Michael Hsu; Bharath Srinivas; Jyothi Kumar; Rajagopalan Subramanian; Julie Andersen
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

Review 5.  Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications.

Authors:  Li Zhou; Dong-Ya Zhu
Journal:  Nitric Oxide       Date:  2009-03-17       Impact factor: 4.427

Review 6.  Nitric oxide and reactive oxygen species in Parkinson's disease.

Authors:  Kim Tieu; Harry Ischiropoulos; Serge Przedborski
Journal:  IUBMB Life       Date:  2003-06       Impact factor: 3.885

7.  S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.

Authors:  Jianguo Fang; Tomohiro Nakamura; Dong-Hyung Cho; Zezong Gu; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

8.  Presynaptic cell type-dependent regulation of GABAergic synaptic transmission by nitric oxide in rat insular cortex.

Authors:  K Yamamoto; H Takei; Y Koyanagi; N Koshikawa; M Kobayashi
Journal:  Neuroscience       Date:  2014-10-05       Impact factor: 3.590

9.  Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke.

Authors:  Mushfiquddin Khan; Manu Jatana; Chinnasamy Elango; Ajaib Singh Paintlia; Avtar K Singh; Inderjit Singh
Journal:  Nitric Oxide       Date:  2006-03-09       Impact factor: 4.427

10.  Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

Authors:  Thomas Dehmer; Michael T Heneka; Magdalena Sastre; Johannes Dichgans; Jörg B Schulz
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

View more
  24 in total

Review 1.  The antipsychotic landscape: dopamine and beyond.

Authors:  Paul D Morrison; Robin M Murray
Journal:  Ther Adv Psychopharmacol       Date:  2018-01-23

Review 2.  New psychoactive substances: Pharmacology influencing UK practice, policy and the law.

Authors:  David Nutt
Journal:  Br J Clin Pharmacol       Date:  2020-02-04       Impact factor: 4.335

3.  Neuroprotective effects of some seaweeds against Zn - induced neuronal damage in HT-22 cells via modulation of redox imbalance, inhibition of apoptosis and acetylcholinesterase activity.

Authors:  Tosin A Olasehinde; Ademola O Olaniran; Anthony I Okoh
Journal:  Metab Brain Dis       Date:  2019-07-26       Impact factor: 3.584

Review 4.  The Contribution of Serotonergic Receptors and Nitric Oxide Systems in the Analgesic Effect of Acetaminophen: An Overview of the Last Decade.

Authors:  Yeşim Hamurtekin; Ammar Nouilati; Cansu Demirbatir; Emre Hamurtekin
Journal:  Turk J Pharm Sci       Date:  2020-02-19

5.  Human endogenous retrovirus W env increases nitric oxide production and enhances the migration ability of microglia by regulating the expression of inducible nitric oxide synthase.

Authors:  Ran Xiao; Shan Li; Qian Cao; Xiuling Wang; Qiujin Yan; Xiaoning Tu; Ying Zhu; Fan Zhu
Journal:  Virol Sin       Date:  2017-06-23       Impact factor: 4.327

Review 6.  The protective role of exercise against age-related neurodegeneration.

Authors:  Alyson Sujkowski; Luke Hong; R J Wessells; Sokol V Todi
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895

7.  Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation.

Authors:  Madia Letizia Stama; Joanna Ślusarczyk; Enza Lacivita; Liliya N Kirpotina; Igor A Schepetkin; Katarzyna Chamera; Chiara Riganti; Roberto Perrone; Mark T Quinn; Agnieszka Basta-Kaim; Marcello Leopoldo
Journal:  Eur J Med Chem       Date:  2017-09-18       Impact factor: 6.514

8.  Combination of donepezil and gallic acid improves antioxidant status and cholinesterases activity in aluminum chloride-induced neurotoxicity in Wistar rats.

Authors:  Tajudeen O Obafemi; Olutumise V Owolabi; Benjamin O Omiyale; Blessing A Afolabi; Oluwafemi A Ojo; Amos Onasanya; Isaac A I Adu; Damilare Rotimi
Journal:  Metab Brain Dis       Date:  2021-05-12       Impact factor: 3.584

9.  Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.

Authors:  Krzysztof Milewski; Małgorzata Bogacińska-Karaś; Inez Fręśko; Wojciech Hilgier; Radosław Jaźwiec; Jan Albrecht; Magdalena Zielińska
Journal:  Int J Mol Sci       Date:  2017-11-02       Impact factor: 5.923

Review 10.  Hydrogen sulfide, nitric oxide, and neurodegenerative disorders.

Authors:  Sandesh Panthi; Sumeet Manandhar; Kripa Gautam
Journal:  Transl Neurodegener       Date:  2018-02-13       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.